Cervical Cancer
Reports advance knowledge in cervical cancer research
Published in Cancer Weekly, December 27th, 2005
Study 1: Characteristic molecular changes identified by cDNA arrays in cervical cells can enhance understanding of cervical cancer.
"One of the most frequent malignancies in women worldwide is carcinoma of the uterine cervix," researchers in Mexico report. "High-risk human papillomavirus (HPV) infection is considered the most important etiological factor of uterine cervical cancer. The aim" of their study "was to identify novel cellular genes that could potentially act as predictive molecular markers for human cervical cancer by means of cDNA arrays."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-12-27)
More Articles from Cancer Weekly
- Diet & Nutrition
Use of dietary supplements might have adverse interactions with chemotherapy - Drug Development
Novel cis-diamminedichloroplatinum(II) analogues inhibited cancer cell growth - Gene Research
Use of bioinformatics and genome analysis aids in discovery of new cancer therapeutics - Acoustic Neuromas
New procedure allows those suffering from a specialized brain tumor to preserve their hearing - Alzheimer Disease
Microglial cell uptake of amyloid beta is promoted by protein up-regulation - Antisense Technology
Promoter hypomethylation marks the progression of chronic myeloid leukemia - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
